Concepedia

Xingyu Mu

XM

15

Publications

596

Citations

13

H-Index

2013

Active since

Affiliations

Shanghai First People's Hospital(Current)

Shanghai Jiao Tong University

Fudan University

Shanghai University of Traditional Chinese Medicine

Huashan Hospital

Xingyu Mu is an author at Shanghai First People's Hospital specializing in medicine, urology, and cell biology.

Top concepts

Publications per year

2013–2024

15

Publications

15

FTO modifies the m6A level of MALAT and promotes bladder cancer progression

Le Tao, Xingyu Mu, Haige Chen et al. · Clinical and Translational Medicine · 2021 · 170 citations · Full text

RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment

Xingyu Mu, R. Wang, Zhixian Yao et al. · Molecular Immunology · 2019 · 60 citations

, , +7

ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.

Jiantao Xiao, Qing Shi, Weiguo Li et al. · PubMed · 2018 · 52 citations · Full text

, , +20

Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy

Ke Wu, Mingyue Tan, Juntao Jiang et al. · Clinical Immunology · 2018 · 43 citations

, , +7

microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog

Mingyue Tan, Xingyu Mu, Zhihong Liu et al. · Biochemical and Biophysical Research Communications · 2017 · 41 citations

, , +11

Rows per page

1–5 of 15